• Explore /
  • Poster
  • / A phase II study of perioperative mFOLFOX chemotherapy plus pembrolizumab combination in patients with potentially resectable adenocarcinoma of the esophageal, gastroesophageal junction (GEJ), and stomach.

A phase II study of perioperative mFOLFOX chemotherapy plus pembrolizumab combination in patients with potentially resectable adenocarcinoma of the esophageal, gastroesophageal junction (GEJ), and stomach.

Abstract Video & Slides Poster

Authors

null

Weijing Sun

University of Kansas Medical Center, Kansas City, KS

Weijing Sun , Anwaar Saeed , Raed Moh'd Taiseer Al-Rajabi , Anup Kasi , Nirmal K Veeramachaneni , Mazin Mazin Al-Kasspooles , Joaquina Celebre Baranda , Milind Phadnis , Andrew K. Godwin , Mojtaba Olyaee , Rashna Madan , Alykhan Nagji , Stephen K. Williamson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03488667

DOI

10.1200/JCO.2022.40.4_suppl.329

Abstract #

329

Poster Bd #

G7

Abstract Disclosures

Similar Posters

First Author: Weijing Sun

First Author: Manish A. Shah

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.

Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.

First Author: Janice Zhao

First Author: Patricio Eduardo Yanez